Cardiac Safety Services Market Analysis: Major Players, Lucrative Segments And Top Geographies
3 Jul, 2023
The global cardiac safety services market size is expected to grow from $0.84 billion in 2022 to $0.94 billion in 2023 at a compound annual growth rate (CAGR) of 12.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cardiac safety services market size is expected to reach $1.41 billion in 2027 at a CAGR of 10.5%.
Global Cardiac Safety Services Market Key Driver
The rising frequency of cardiovascular disorders is likely to drive the growth of the cardiac safety services market in the coming years. Cardiovascular diseases encompass a wide range of conditions that affect the heart and blood arteries, including peripheral arterial disease, cerebrovascular disease, coronary heart disease, and others. Cardiac safety services are concerned with heart health and safety monitoring, recognising factors that contribute to cardiovascular disease before disease manifestation, and so assisting in the implementation of preventative measures and lowering the risk of mortality. As a result, the rising frequency of cardiovascular disorders is propelling the cardiac safety services market forward.
Get a sample of the global cardiac safety services market reportGlobal Cardiac Safety Services Market Segments
The global cardiac safety services market is segmented:
1) By Services: ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read Of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies, Other services
2) By Phase: Phase 1, Phase 2, Phase 3
3) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute
4) By Geography: The regions covered in the cardiac safety services market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global cardiac safety services market.
Major Cardiac Safety Services Industry Players
Laboratory Corporation of America Holdings, Banook Group, Pharmaceutical Product Development Inc, Biotrial Research, Certara Inc, Celerion Inc., Medpace Holdings Inc., Ncardia, Richmond Pharmacology Ltd., PhysioStim, SGS S.A, Koninklijke Philips N.V., Clario, NEXEL Co. Ltd, Eurofins Scientific, InBody USA, Spaulding Clinical Research LLC, OMRON Healthcare Inc
Get the full global cardiac safety services market report
Cardiac Safety Services Market Overview
Cardiac safety services refer to offering services related to monitoring heart safety by giving the required support and help in designing clinical trials and other research. Cardiac safety services typically offer assistance with planning clinical trials and other investigations necessary to maintain cardiac safety.
Cardiac Safety Services Global Market Report 2023 provides data on the global cardiac safety services market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cardiac safety services market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.